Polar Capital Holdings PLC Moon Lake Immunotherapeutics Transaction History
Polar Capital Holdings PLC
- $16 Billion
- Q1 2024
A detailed history of Polar Capital Holdings PLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Polar Capital Holdings PLC holds 857,957 shares of MLTX stock, worth $34.4 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
857,957
Previous 937,115
8.45%
Holding current value
$34.4 Million
Previous $56.6 Million
23.85%
% of portfolio
0.27%
Previous 0.4%
Shares
7 transactions
Others Institutions Holding MLTX
# of Institutions
135Shares Held
56MCall Options Held
379KPut Options Held
402K-
Bvf Inc San Francisco, CA21.8MShares$873 Million32.73% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$341 Million24.56% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.58MShares$104 Million1.56% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.31MShares$92.7 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.28MShares$91.7 Million0.23% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.48B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...